TrialCardiovascular drugs and therapy2023

A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients.

Peter Winkle et al.PubMed ↗Publisher ↗

No numbers read from the abstract.